ProShare Advisors
REGN icon

ProShare Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$88.9M Buy
169,343
+6,051
+4% +$3.18M 0.18% 133
2025
Q1
$104M Buy
163,292
+17,157
+12% +$10.9M 0.23% 120
2024
Q4
$104M Buy
146,135
+26,018
+22% +$18.5M 0.24% 113
2024
Q3
$126M Buy
120,117
+6,906
+6% +$7.26M 0.31% 100
2024
Q2
$119M Sell
113,211
-11,992
-10% -$12.6M 0.32% 102
2024
Q1
$121M Buy
125,203
+21,604
+21% +$20.8M 0.32% 101
2023
Q4
$91M Sell
103,599
-18,022
-15% -$15.8M 0.28% 104
2023
Q3
$100M Buy
121,621
+12,984
+12% +$10.7M 0.31% 102
2023
Q2
$78.1M Sell
108,637
-5,831
-5% -$4.19M 0.23% 104
2023
Q1
$94.1M Buy
114,468
+9,788
+9% +$8.04M 0.29% 98
2022
Q4
$75.5M Sell
104,680
-14,924
-12% -$10.8M 0.27% 98
2022
Q3
$82.4M Sell
119,604
-23,334
-16% -$16.1M 0.32% 93
2022
Q2
$84.5M Sell
142,938
-64,197
-31% -$37.9M 0.28% 101
2022
Q1
$145M Sell
207,135
-8,932
-4% -$6.24M 0.31% 92
2021
Q4
$136M Buy
216,067
+63,874
+42% +$40.3M 0.27% 107
2021
Q3
$92.1M Buy
152,193
+16,450
+12% +$9.96M 0.26% 110
2021
Q2
$75.8M Sell
135,743
-4,301
-3% -$2.4M 0.22% 116
2021
Q1
$66.3M Buy
140,044
+19,031
+16% +$9M 0.21% 124
2020
Q4
$58.5M Buy
121,013
+16,493
+16% +$7.97M 0.22% 119
2020
Q3
$58.5M Buy
104,520
+18,638
+22% +$10.4M 0.27% 103
2020
Q2
$53.6M Buy
85,882
+11,959
+16% +$7.46M 0.29% 97
2020
Q1
$36.1M Sell
73,923
-30,717
-29% -$15M 0.26% 99
2019
Q4
$39.3M Sell
104,640
-442
-0.4% -$166K 0.18% 112
2019
Q3
$29.2M Buy
105,082
+2,893
+3% +$803K 0.16% 113
2019
Q2
$32M Sell
102,189
-895
-0.9% -$280K 0.19% 110
2019
Q1
$42.3M Sell
103,084
-2,169
-2% -$891K 0.25% 104
2018
Q4
$39.3M Buy
105,253
+13,338
+15% +$4.98M 0.28% 98
2018
Q3
$37.1M Sell
91,915
-17,851
-16% -$7.21M 0.25% 96
2018
Q2
$37.9M Sell
109,766
-7,194
-6% -$2.48M 0.25% 101
2018
Q1
$40.3M Buy
116,960
+130
+0.1% +$44.8K 0.26% 103
2017
Q4
$43.9M Buy
116,830
+17,043
+17% +$6.41M 0.3% 91
2017
Q3
$44.6M Buy
99,787
+10,478
+12% +$4.68M 0.41% 74
2017
Q2
$43.9M Buy
89,309
+3,025
+4% +$1.49M 0.44% 71
2017
Q1
$33.4M Sell
86,284
-12,964
-13% -$5.02M 0.35% 76
2016
Q4
$36.4M Buy
99,248
+7,307
+8% +$2.68M 0.4% 73
2016
Q3
$37M Sell
91,941
-24,704
-21% -$9.93M 0.52% 68
2016
Q2
$40.7M Buy
116,645
+1,390
+1% +$485K 0.52% 64
2016
Q1
$41.5M Sell
115,255
-14,503
-11% -$5.23M 0.57% 30
2015
Q4
$70.4M Buy
129,758
+7,064
+6% +$3.83M 0.85% 19
2015
Q3
$57.1M Buy
122,694
+5,534
+5% +$2.57M 0.8% 19
2015
Q2
$59.8M Sell
117,160
-11,278
-9% -$5.75M 0.83% 18
2015
Q1
$58M Buy
128,438
+15,623
+14% +$7.05M 0.68% 22
2014
Q4
$46.3M Buy
112,815
+27,202
+32% +$11.2M 0.54% 31
2014
Q3
$30.9M Buy
85,613
+16,265
+23% +$5.86M 0.41% 36
2014
Q2
$19.6M Sell
69,348
-13,827
-17% -$3.91M 0.25% 65
2014
Q1
$25M Buy
83,175
+6,351
+8% +$1.91M 0.31% 53
2013
Q4
$21.1M Buy
76,824
+24,894
+48% +$6.85M 0.32% 59
2013
Q3
$16.2M Buy
51,930
+4,648
+10% +$1.45M 0.39% 36
2013
Q2
$10.6M Buy
+47,282
New +$10.6M 0.21% 86